Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,766.50
Change: 36.50 (2.11%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,766.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BUZZ-U.S. Stocks on the Move-Kamada, Mitek, Stereotaxis, Shoe Carnival

Thu, 04th Sep 2014 14:12

(For faster updates on individual market-movers, Eikon usersplease use search string "STXBZ US"; for more market insights,including options activity, ; for the Day Aheadnewsletter, http://link.reuters.com/mex49s; for the Morning NewsCall newsletter, http://link.reuters.com/nex49s)

U.S. stocks opened slightly higher on Thursday, after theEuropean Central Bank cut interest rates to record lows and aflurry of economic data indicated the U.S. economy was steadilyimproving. The Dow Jones industrial average was up 0.37percent at 17,141.44, the S&P 500 was up 0.40 percent at2,008.66 and the Nasdaq Composite was up 0.2 percent4,581.71.

** SHOE CARNIVAL INC, $19.635, -11.39 pct

The footwear retailer reported lower-than-expected secondquarter sales and profit as fewer customers visited its storesand expenses rose. Its profit has now missed estimates for thelast three quarters. The company forecast third quartercomparable-store sales to either decline up to 1 percent or growup to 1 percent.

Susquehanna Financial Group analysts cut price target to $24from $25 on the stock which had fallen 24 percent this year upto Wednesday's close.

** SOLARCITY CORP, $71.3, +5.29 pct

The solar panel installer said it would open 20 newoperations centres in seven U.S. states. The company, backed byTesla Motors Inc founder Elon Musk, says new centersexpected to create more than 600 additional jobs.

** BAZAARVOICE INC, $8.09, +7.87 pct

B. Riley & Co raises price target on stock of the softwaremaker to $10 from $9.75, saying net new client additions in Q1were significantly higher than it had estimated.

Bazaarvoice, which provides businesses online and socialmedia tools to interact with customers, reportedhigher-than-expected Q1 revenue and smaller-than-expected losson Wednesday

** VERIFONE SYSTEMS INC, $35.93, +4.02 pct

The credit card swipe machine maker raised full-year revenueforecast for the third time, encouraged by strong sales ofdevices that can accept chip-embedded credit cards. VeriFonealso raised full-year profit forecast and reportedbetter-than-expected third quarter revenue.

The company is benefiting as U.S. retailers upgrade theirpoint-of-sale terminals to systems compatible with more securecredit cards in the wake of several data breaches. Up toWednesday's close, the stock had risen nearly 30 percent thisyear.

** ARLINGTON ASSET INVESTMENT CORP, $27.14, -4.40 pct

The mortgage investor said it was offering 2.75 millionshares of Class A common stock - 14 percent of its totaloutstanding shares - at $27.61 each, a 2.7 pct discount toWednesday's close.

Arlington said it plans to use the proceeds to acquireassets. Up to Wednesday's close, the stock had risen 7.6 percentthis year.

** STEREOTAXIS INC,$3.31, +16.14 pct

The medical device maker received U.S. FDA's marketingapproval for its device used during procedures to assess heartactivity. The device, called Vdrive Robotic Navigation System,is designed to remotely control catheter during such procedures.

** KAMADA LTD, $5.6, -21.79 pct

The Israel-based drugmaker's experimental drug to treat aninherited condition that raises the risk of lung and liverdisease failed in a mid-stage study. The drug, Inhaled Alpha-1Antitrypsin, did not show a statistically significantdifference, compared with a placebo. Glassia, an intravenousversion of the drug, is already being marketed by Baxter Inc in the United States.

** CIENA CORP, $19.13, -6.50 pct

The network equipment forecast fourth quarter revenue of$570 million-$610 million, below the average analyst estimate of$628.9 million. The company said it expects fourth quarteradjusted gross margin in the high 30s to low 40s percent range.

** MITEK SYSTEMS INC, $3.46, +45.99 pct

The mobile imaging software maker agreed on Wednesday tosettle all pending litigation with financial services group USAAover five of its patents relating to image capture on mobiledevices. Mitek's lawsuit filed in 2012 also included allegationsof misappropriation of trade secrets, breach of contract andfraud. The company said neither party will make any payment oradmit liability on any claims.

** GOPRO INC, $54.865, -3.51 pct

J.P. Morgan cut its rating on the stock of the maker of camera makers to "neutral" from "overweight", saying the stockis trading above its price target of $51. The median pricetarget on stock is $46.50. Of nine analysts covering the stock,2 have "buy" ratings and 7 have "hold" or equivalent ratings. Upto Wednesday's close, the stock had risen 137 percent since itsdebut on June 26.

** MEMORIAL PRODUCTION PARTNERS LP, $22.28, -3.80pct

The oil and gas producer said it would offer 13 millioncommon units; representing 18 percent of outstanding shares asof Wednesday. The company said it plans to use net proceeds fromthe underwritten public offering to pay down debt.

** MATTRESS FIRM HOLDING CORP, $63.443, +11.68 pct

The company said it would buy privately held beddingretailer The Sleep Train Inc for $425 million, its sixth andlargest acquisition announced in the past year, to expand itspresence on the West Coast.

** NEWLINK GENETICS CORP, $26.73, +2.93 pct

NewLink Genetics said the U.S. Food and Drug Administrationallowed the company to start testing an experimental Ebolavaccine in humans.

The move follows a decision to begin initial human testingof a GlaxoSmithKline vaccine this month and an approvalto fast track tests of a Johnson & Johnson vaccine.

** TIBCO SOFTWARE INC, $22, +4.56 pct

The business software maker said it was reviewing itsstrategic and financial alternatives as part of a processinitiated by its board on Aug. 16 to maximize shareholder value. The company has formed a special committee of independentdirectors to undertake the review.

** MATRIX SERVICE CO, $22.29, -23.48 pct

The engineering and construction services provider's fourthquarter revenue and profit missed analysts' estimates due to a47 percent rise in costs. Revenue from the company's oil, gasand chemical segment, which provides construction andmaintenance services to North American oil producers, fell about22 percent to $52.1 million. Matrix also forecast full-yearearnings below estimates.

** PVH CORP, $127.74, +9.06 pct

The apparel company's second quarter profit beatexpectations, helped by strong sales of its TommyHilfiger-branded clothes. PVH cut its full-year revenue forecastto $8.4 billion from $8.5 billion, but it reaffirmed its profitforecast.

** JOY GLOBAL INC, $61.56, -1.03 pct

The mining equipment maker posted lower-than-expectedquarterly revenue and profit and the company narrowed itsfull-year earnings forecast range as coal miners cut spendingdue to weak coal prices amid an oversupply. (Compiled by Rohit T.K. in Bangalore; Editing by Joyjeet Das)

More News
3 Oct 2023 11:59

LONDON MARKET MIDDAY: HSBC and StanChart help FTSE 100 outperform

(Alliance News) - London's FTSE 100 grew in confidence as Tuesday morning progressed, going into the afternoon in the green and outperforming European peers.

Read more
25 Sep 2023 09:13

LONDON BROKER RATINGS: Jefferies raises AstraZeneca to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
25 Sep 2023 08:37

TOP NEWS: GSK's Arexvy vaccine approved for adults over 60 in Japan

(Alliance News) - GSK PLC on Monday said the Japan Ministry of Health, Labour & Welfare has approved Arexvy for adults over 60.

Read more
25 Sep 2023 07:28

GSK's RSV vaccine gets approval in Japan

(Sharecast News) - GSK announced on Monday that its vaccine, Arexvy, has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for preventing respiratory syncytial virus (RSV) disease in adults aged 60 and over.

Read more
19 Sep 2023 09:30

GSK says new HIV PrEP medication authorised by European Commission

(Alliance News) - GSK PLC on Tuesday said the European Commission has authorised ViiV Healthcare's "superior" drug Apretude to reduce the risk of sexually acquired HIV-1 infection.

Read more
18 Sep 2023 09:40

LONDON BROKER RATINGS: Jefferies likes Energean; JPMorgan raises IDS

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
18 Sep 2023 07:57

LONDON BRIEFING: Phoenix Group hails "impressive" first-half

(Alliance News) - Stocks in London are called lower on Monday, as investors focus on the week's upcoming central bank decisions.

Read more
18 Sep 2023 07:18

US FDA approves GSK treatment for myelofibrosis

(Sharecast News) - GSK announced on Monday that the US Food and Drug Administration (FDA) has granted approval for 'Ojjaara', or momelotinib, as a treatment for adults suffering from intermediate or high-risk myelofibrosis with anaemia, including cases of primary myelofibrosis or secondary myelofibrosis.

Read more
15 Sep 2023 21:52

GSK's Ojjaara approved in US for myelofibrosis patients with anaemia

(Alliance News) - GSK PLC on Friday said Ojjaara, also known as momelotinib, has been approved in the US and the "first and only" treatment indicated for myelofibrosis patients with anaemia.

Read more
11 Sep 2023 08:24

Japan accepts GSK's regulatory filing for momelotinib for blood cancer

(Alliance News) - GSK PLC on Monday reported regulatory progress for momelotinib, as Japan's Ministry of Health, Labour & Welfare accepted a review for the blood cancer-focused drug.

Read more
11 Sep 2023 07:54

LONDON BRIEFING: Restaurant Group sells Frankie & Benny's and Chiquito

(Alliance News) - Stocks in London are called higher on Monday, ahead of a busy week of interest rate decisions and economic data.

Read more
6 Sep 2023 09:32

LONDON BROKER RATINGS: Shore says 'buy' B&M; Peel Hunt likes Halfords

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
4 Sep 2023 06:00

More UK babies to need hospital treatment over delay of GSK's RSV jab

(Alliance News) - The nation's top children's doctor has warned a delay on a new vaccine to combat respiratory syncytial virus, or RSV, will mean more babies and infants will need hospital treatment this winter.

Read more
1 Sep 2023 09:11

GSK antibody accepted for Japan review, Goldman Sachs reduces stake

(Alliance News) - GSK PLC on Friday said a new drug application for its monoclonal antibody mepolizumab has been accepted for review by the Japanese government.

Read more
1 Sep 2023 07:49

LONDON BRIEFING: Stocks seen higher; UK house prices continue to fall

(Alliance News) - Stocks in London are set to open higher on Friday as markets looked ahead to a data-heavy day.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.